Xiaoyan Sun1, David Salat, Kristen Upchurch, Rebecca Deason, Neil Kowall, Andrew Budson. 1. From the *Department of Neurology and †Center for Translational Neuroscience, ‡VA Boston Healthcare System, Boston, MA; §Boston University School of Medicine, Boston, MA; ∥Neuroimaging Research for Veterans Center, VA Boston Healthcare System, Boston, MA; ¶Department of Radiology, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA; and **Department of Psychology, Texas State University, San Marcos, TX.
Abstract
BACKGROUND: Accumulating evidence shows that gradual loss of white matter integrity plays an important role in the development of Alzheimer disease (AD). OBJECTIVE: The aim of this research was to study the microstructural integrity of white matter in AD in vivo. METHODS: Global fractional anisotropy, global axial diffusivity (AxD), and global radial diffusivity (RD) were analyzed in subjects with normal controls (NC), mild cognitive impairment (MCI), and AD using Alzheimer's Disease Neuroimaging Initiative data (total N = 210). We further compared specific white matter tracts among the 3 groups. RESULTS: Compared with the NC group, the MCI group had significantly increased global AxD and global RD. Compared with the NC and MCI groups, the AD group had significantly decreased global fractional anisotropy, increased global AxD, and increased global RD. With regard to specific white matter tracts, in the MCI group, we found increased AxD and increased RD in the external capsule, part of the lateral cholinergic pathway, in addition to the tracts connecting the limbic regions, predominantly in the left hemisphere. In the AD group, white matter abnormalities were widespread, including in the external capsule (cholinergic pathway) and limbic region tracts as well as tracts connecting anterior to posterior regions bilaterally. CONCLUSIONS: The radiographic manifestation of damaged white matter microstructural integrity in the cholinergic pathway in MCI patients may provide a rational basis for the use of cholinesterase inhibitor drugs in the MCI stage of AD.
BACKGROUND: Accumulating evidence shows that gradual loss of white matter integrity plays an important role in the development of Alzheimer disease (AD). OBJECTIVE: The aim of this research was to study the microstructural integrity of white matter in AD in vivo. METHODS: Global fractional anisotropy, global axial diffusivity (AxD), and global radial diffusivity (RD) were analyzed in subjects with normal controls (NC), mild cognitive impairment (MCI), and AD using Alzheimer's Disease Neuroimaging Initiative data (total N = 210). We further compared specific white matter tracts among the 3 groups. RESULTS: Compared with the NC group, the MCI group had significantly increased global AxD and global RD. Compared with the NC and MCI groups, the AD group had significantly decreased global fractional anisotropy, increased global AxD, and increased global RD. With regard to specific white matter tracts, in the MCI group, we found increased AxD and increased RD in the external capsule, part of the lateral cholinergic pathway, in addition to the tracts connecting the limbic regions, predominantly in the left hemisphere. In the AD group, white matter abnormalities were widespread, including in the external capsule (cholinergic pathway) and limbic region tracts as well as tracts connecting anterior to posterior regions bilaterally. CONCLUSIONS: The radiographic manifestation of damaged white matter microstructural integrity in the cholinergic pathway in MCI patients may provide a rational basis for the use of cholinesterase inhibitor drugs in the MCI stage of AD.
Authors: Susumu Mori; Kenichi Oishi; Hangyi Jiang; Li Jiang; Xin Li; Kazi Akhter; Kegang Hua; Andreia V Faria; Asif Mahmood; Roger Woods; Arthur W Toga; G Bruce Pike; Pedro Rosa Neto; Alan Evans; Jiangyang Zhang; Hao Huang; Michael I Miller; Peter van Zijl; John Mazziotta Journal: Neuroimage Date: 2008-01-03 Impact factor: 6.556
Authors: Nikki H Stricker; David H Salat; Jessica M Foley; Tyler A Zink; Ida L Kellison; Craig P McFarland; Laura J Grande; Regina E McGlinchey; William P Milberg; Elizabeth C Leritz Journal: J Int Neuropsychol Soc Date: 2013-07-01 Impact factor: 2.892
Authors: Christian Bocti; Richard H Swartz; Fu-Qiang Gao; Demetrios J Sahlas; Pearl Behl; Sandra E Black Journal: Stroke Date: 2005-09-22 Impact factor: 7.914
Authors: Djyldyz Sydykova; Robert Stahl; Olaf Dietrich; Michael Ewers; Maximilian F Reiser; Stefan O Schoenberg; Hans-Jürgen Möller; Harald Hampel; Stefan J Teipel Journal: Cereb Cortex Date: 2006-12-12 Impact factor: 5.357
Authors: D H Salat; D S Tuch; A J W van der Kouwe; D N Greve; V Pappu; S Y Lee; N D Hevelone; A K Zaleta; J H Growdon; S Corkin; B Fischl; H D Rosas Journal: Neurobiol Aging Date: 2010-02 Impact factor: 4.673
Authors: Stefan J Teipel; Michel Grothe; Simone Lista; Nicola Toschi; Francesco G Garaci; Harald Hampel Journal: Med Clin North Am Date: 2013-02-01 Impact factor: 5.456
Authors: Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie M Shaw; Arthur W Toga; John Q Trojanowski Journal: Alzheimers Dement Date: 2017-03-22 Impact factor: 21.566
Authors: Steffan K Soosman; Nelly Joseph-Mathurin; Meredith N Braskie; Yvette M Bordelon; David Wharton; Maria Casado; Giovanni Coppola; Holly McCallum; Marc Nuwer; Pedro Coutin-Churchman; Liana G Apostolova; Tammie Benzinger; John M Ringman Journal: Neurobiol Aging Date: 2016-08-08 Impact factor: 4.673